A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
Soligenix
Prescient Therapeutics, Ltd.
Ossium Health, Inc.
Chengdu Zenitar Biomedical Technology Co., Ltd
Seagen Inc.